Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALFRED C BURRIS

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1578738639
CMS profile
26432
Location
MANASSAS, VA

General Payments · PY2018–2024

$6,493.70

  • Reported across 182 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$688.55

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $688.55 15

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,859.74 56
PY2019 $1,196.08 46
PY2020 $292.86 16
PY2021 $447.32 21
PY2022 $396.84 7
PY2023 $612.31 21
PY2024 $688.55 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $121.56 12/06/2024 Food and Beverage Undisputed 01/23/2026 1125135455 CMS
Actelion Pharmaceuticals US, Inc. $32.75 03/20/2024 Food and Beverage Undisputed 01/23/2026 1078922211 CMS
Actelion Pharmaceuticals US, Inc. $40.33 08/07/2024 Food and Beverage Undisputed 01/23/2026 1078922207 CMS
Actelion Pharmaceuticals US, Inc. $43.80 09/11/2024 Food and Beverage Undisputed 01/23/2026 1078922201 CMS
Bayer Healthcare Pharmaceuticals Inc. $25.52 05/17/2024 Food and Beverage Undisputed 01/23/2026 1086242192 CMS
Boston Scientific Corporation $113.33 02/21/2024 Food and Beverage Undisputed 01/23/2026 1092332358 CMS
Boston Scientific Corporation $35.97 04/04/2024 Food and Beverage Undisputed 01/23/2026 1092332352 CMS
Boston Scientific Corporation $49.87 07/29/2024 Food and Beverage Undisputed 01/23/2026 1092332354 CMS
Boston Scientific Corporation $4.67 09/27/2024 Food and Beverage Undisputed 01/23/2026 1092332350 CMS
Boston Scientific Corporation $57.64 11/21/2024 Food and Beverage Undisputed 01/23/2026 1092332356 CMS
E.R. Squibb & Sons, L.L.C. $27.50 10/23/2024 Food and Beverage Undisputed 01/23/2026 1101692274 CMS
Inari Medical, Inc. $56.70 07/23/2024 Food and Beverage Undisputed 01/23/2026 1140066881 CMS
Novo Nordisk Inc $24.39 07/30/2024 Food and Beverage Undisputed 01/23/2026 1096729849 CMS
PFIZER INC. $27.88 02/21/2024 Food and Beverage Undisputed 01/23/2026 1131305131 CMS
PFIZER INC. $26.64 11/13/2024 Food and Beverage Undisputed 01/23/2026 1131082881 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.